Literature DB >> 33456172

Pediatric spontaneous tension pneumothorax in Langerhans cell histiocytosis.

Andrew L Juergens1, Archana K Reddy2, Matthew W Fannell1, Guy H Grayson3.   

Abstract

Langerhans cell histiocytosis is a rare hematologic disorder caused by the proliferation of specialized dendritic cells. Pulmonary manifestations occur in 20% to 50% of multisystem disease, but isolated pulmonary disease is rare. Spontaneous pneumothorax occurs in up to 10% of pediatric pulmonary cases. We present the case of a 3-year-old boy who presented for tachypnea and chest pain with cough, rhinorrhea, and congestion. He was discharged with a diagnosis of upper respiratory infection. The patient returned to the emergency department and was found to have a tension pneumothorax, which was emergently treated with thoracostomy. The subsequent workup revealed Langerhans cell histiocytosis with pulmonary disease and jaw involvement. Although tension pneumothorax is often associated with trauma, several medical conditions are predispositional.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Histiocytosis; Langerhans cell; pediatric emergency medicine; pneumothorax

Year:  2020        PMID: 33456172      PMCID: PMC7787669          DOI: 10.1080/08998280.2020.1826215

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  Recurrent pneumomediastinum and pneumothorax in Langerhans cell histiocytosis.

Authors:  S M Yule; J R Hamilton; K P Windebank
Journal:  Med Pediatr Oncol       Date:  1997-08

Review 2.  Langerhans cell histiocytosis.

Authors:  Nanette Grana
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

3.  Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.

Authors:  Isaac Odame; Patricia Li; Loretta Lau; Wendy Doda; Mary Noseworthy; Paul Babyn; Sheila Weitzman
Journal:  Pediatr Blood Cancer       Date:  2006-12       Impact factor: 3.167

4.  The multiple faces of Langerhans cell histiocytosis in childhood: A gentle reminder.

Authors:  Maria Papadopoulou; Paraskevi Panagopoulou; Anastasia Papadopoulou; Emmanuel Hatzipantelis; Ioannis Efstratiou; Assimina Galli-Tsinopoulou; Efimia Papadopoulou-Alataki
Journal:  Mol Clin Oncol       Date:  2017-12-18

5.  Outcome in children with pulmonary Langerhans cell Histiocytosis.

Authors:  Jorge Braier; Antonio Latella; Blanca Balancini; Claudio Castaños; Diego Rosso; Guillermo Chantada; Mario Ripoli; Julio Goldberg
Journal:  Pediatr Blood Cancer       Date:  2004-12       Impact factor: 3.167

6.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

7.  Incidence of Langerhans cell histiocytosis in children: a population-based study.

Authors:  Helen Stålemark; Evaldas Laurencikas; Jenny Karis; Désirée Gavhed; Bengt Fadeel; Jan-Inge Henter
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

8.  Lung involvement in Langerhans' cell histiocytosis: prevalence, clinical features, and outcome.

Authors:  S Y Ha; P Helms; M Fletcher; V Broadbent; J Pritchard
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

9.  Congenital Langerhans cell histiocytosis: the self-healing variety.

Authors:  Mandeep Walia; Premila Paul; Sharmila Mishra; Rajesh Mehta
Journal:  J Pediatr Hematol Oncol       Date:  2004-06       Impact factor: 1.289

10.  Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Authors:  Riccardo Haupt; Milen Minkov; Itziar Astigarraga; Eva Schäfer; Vasanta Nanduri; Rima Jubran; R Maarten Egeler; Gritta Janka; Dragan Micic; Carlos Rodriguez-Galindo; Stefaan Van Gool; Johannes Visser; Sheila Weitzman; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.